159 related articles for article (PubMed ID: 35853090)
1. An insight into the diagnostic and prognostic value of HOX A13's expression in non-muscle invasive bladder cancer.
Setti Boubaker N; Gurtner A; Trabelsi N; Manni I; Blel A; Saadi A; Chakroun M; Naimi Z; Zaghbib S; Ksontini M; Meddeb K; Rammeh S; Ayed H; Chebil M; Piaggio G; Ouerhani S
J Clin Lab Anal; 2022 Sep; 36(9):e24606. PubMed ID: 35853090
[TBL] [Abstract][Full Text] [Related]
2. Deregulation of HOX B13 expression in urinary bladder cancer progression.
Marra L; Cantile M; Scognamiglio G; Perdonà S; La Mantia E; Cerrone M; Gigantino V; Cillo C; Caraglia M; Pignata S; Facchini G; Botti G; Chieffi S; Chieffi P; Franco R
Curr Med Chem; 2013 Feb; 20(6):833-9. PubMed ID: 23276138
[TBL] [Abstract][Full Text] [Related]
3. The clinical and prognostic value of miR-9 gene expression in Tunisian patients with bladder cancer.
Setti Boubaker N; Cicchillitti L; Said R; Gurtner A; Ayed H; Blel A; Karray O; Essid MA; Gharbi M; Bouzouita A; Rammeh Rommeni S; Chebil M; Piaggio G; Ouerhani S
Mol Biol Rep; 2019 Oct; 46(5):4743-4750. PubMed ID: 31214962
[TBL] [Abstract][Full Text] [Related]
4. A prognostic immune predictor, HLA-DRA, plays diverse roles in non-muscle invasive and muscle invasive bladder cancer.
Piao XM; Kang HW; Jeong P; Byun YJ; Lee HY; Kim K; Seo SP; Kim WT; Lee JY; Ha YS; Choi YH; Moon SK; Yun SJ; Kim WJ
Urol Oncol; 2021 Apr; 39(4):237.e21-237.e29. PubMed ID: 33339725
[TBL] [Abstract][Full Text] [Related]
5. Uncovering the expression patterns and the clinical significance of miR-182, miR-205, miR-27a and miR-369 in patients with urinary bladder cancer.
Setti Boubaker N; Gurtner A; Trabelsi N; Manni I; Ayed H; Saadi A; Naimi Z; Ksontini M; Ayadi M; Blel A; Rammeh S; Chebil M; Piaggio G; Ouerhani S
Mol Biol Rep; 2020 Nov; 47(11):8819-8830. PubMed ID: 33128684
[TBL] [Abstract][Full Text] [Related]
6. The diagnostic applicability of A-type Lamin in non-muscle invasive bladder cancer.
Setti Boubaker N; Gurtner A; Trabelsi N; Manni I; Ayed H; Saadi A; Zaghbib S; Naimi Z; Sahraoui G; Zouari S; Meddeb K; Mrad K; Chebil M; Piaggio G; Ouerhani S
Ann Diagn Pathol; 2021 Oct; 54():151808. PubMed ID: 34438192
[TBL] [Abstract][Full Text] [Related]
7. Dysregulated expression of homebox gene HOXA13 is correlated with the poor prognosis in bladder cancer.
Hu H; Chen Y; Cheng S; Li G; Zhang Z
Wien Klin Wochenschr; 2017 Jun; 129(11-12):391-397. PubMed ID: 27830363
[TBL] [Abstract][Full Text] [Related]
8. High PDL1 mRNA expression predicts better survival of stage pT1 non-muscle-invasive bladder cancer (NMIBC) patients.
Breyer J; Wirtz RM; Otto W; Erben P; Worst TS; Stoehr R; Eckstein M; Denzinger S; Burger M; Hartmann A
Cancer Immunol Immunother; 2018 Mar; 67(3):403-412. PubMed ID: 29150702
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of protocadherin 8 (PCDH8) promoter methylation in non-muscle invasive bladder cancer.
Lin YL; Wang YL; Ma JG; Li WP
J Exp Clin Cancer Res; 2014 Aug; 33(1):68. PubMed ID: 25927589
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Value of BUB1 for Predicting Non-Muscle-Invasive Bladder Cancer Progression.
Piao XM; You C; Byun YJ; Kang HW; Noh J; Lee J; Lee HY; Kim K; Kim WT; Yun SJ; Lee SC; Kang K; Kim YJ
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884561
[TBL] [Abstract][Full Text] [Related]
11. The Role of Prior Bladder Cancer on Recurrence in Patients Treated with Radical Nephroureterectomy.
Martini A; Lonati C; Montorsi F; Briganti A; Colombo R; Necchi A; Simeone C; Zamboni S; Afferi L; Mattei A; Carando R; Ploussard G; Soria F; Marra G; Rouprêt M; Xylinas E; Pradere B; Abufaraj M; D'Andrea D; Shariat SF; Moschini M
Clin Genitourin Cancer; 2022 Jun; 20(3):e190-e198. PubMed ID: 35105509
[TBL] [Abstract][Full Text] [Related]
12. Unraveling UCA1 lncRNA prognostic utility in urothelial bladder cancer.
Avgeris M; Tsilimantou A; Levis PK; Rampias T; Papadimitriou MA; Panoutsopoulou K; Stravodimos K; Scorilas A
Carcinogenesis; 2019 Aug; 40(8):965-974. PubMed ID: 30815670
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Value of the WHO1973 and WHO2004/2016 Classification Systems for Grade in Primary Ta/T1 Non-muscle-invasive Bladder Cancer: A Multicenter European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel Study.
van Rhijn BWG; Hentschel AE; Bründl J; Compérat EM; Hernández V; Čapoun O; Bruins HM; Cohen D; Rouprêt M; Shariat SF; Mostafid AH; Zigeuner R; Dominguez-Escrig JL; Burger M; Soukup V; Gontero P; Palou J; van der Kwast TH; Babjuk M; Sylvester RJ;
Eur Urol Oncol; 2021 Apr; 4(2):182-191. PubMed ID: 33423944
[TBL] [Abstract][Full Text] [Related]
14. Epithelial-To-Mesenchymal Transition and Its Correlation With Clinicopathologic Features in Patients With Urothelial Carcinoma of the Bladder.
Singh R; Ansari JA; Maurya N; Mandhani A; Agrawal V; Garg M
Clin Genitourin Cancer; 2017 Apr; 15(2):e187-e197. PubMed ID: 27601277
[TBL] [Abstract][Full Text] [Related]
15. Snail is an independent prognostic indicator for predicting recurrence and progression in non-muscle-invasive bladder cancer.
Gou Y; Ding W; Xu K; Wang H; Chen Z; Tan J; Xia G; Ding Q
Int Urol Nephrol; 2015 Feb; 47(2):289-93. PubMed ID: 25388353
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Significance of CREB-Binding Protein and CD81 Expression in Primary High Grade Non-Muscle Invasive Bladder Cancer: Identification of Novel Biomarkers for Bladder Cancer Using Antibody Microarray.
Lee MS; Kim JH; Lee JS; Yun SJ; Kim WJ; Ahn H; Park J
PLoS One; 2015; 10(4):e0125405. PubMed ID: 25915404
[TBL] [Abstract][Full Text] [Related]
17. The Splicing Factor PTBP1 Promotes Expression of Oncogenic Splice Variants and Predicts Poor Prognosis in Patients with Non-muscle-Invasive Bladder Cancer.
Bielli P; Panzeri V; Lattanzio R; Mutascio S; Pieraccioli M; Volpe E; Pagliarulo V; Piantelli M; Giannantoni A; Di Stasi SM; Sette C
Clin Cancer Res; 2018 Nov; 24(21):5422-5432. PubMed ID: 30012566
[No Abstract] [Full Text] [Related]
18. Prognostic Implication of Urothelial Stem Cell Markers Differs According to Primary Tumour Location in Non-Muscle-Invasive Bladder Cancer.
Wang L; Zhao J; Yang C; Kuang R; Kazobinka G; Pang Z; Hou T
Cell Physiol Biochem; 2018; 48(6):2364-2373. PubMed ID: 30114689
[TBL] [Abstract][Full Text] [Related]
19. Expression of miR-100 and miR-138 as prognostic biomarkers in non-muscle-invasive bladder cancer.
Blanca A; Sanchez-Gonzalez A; Requena MJ; Carrasco-Valiente J; Gomez-Gomez E; Cheng L; Cimadamore A; Montironi R; Lopez-Beltran A
APMIS; 2019 Aug; 127(8):545-553. PubMed ID: 31231851
[TBL] [Abstract][Full Text] [Related]
20. Identification and validation that up-expression of HOXA13 is a novel independent prognostic marker of a worse outcome in gastric cancer based on immunohistochemistry.
Han Y; Tu WW; Wen YG; Li DP; Qiu GQ; Tang HM; Peng ZH; Zhou CZ
Med Oncol; 2013; 30(2):564. PubMed ID: 23592225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]